Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Trastuzumab"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22CK%22&type=Subject&filter%5B%5D=topic_facet%3A%22Trastuzumab%22
/vufind/Search/Results?lookfor=%22CK%22&type=Subject&filter%5B%5D=topic_facet%3A%22Trastuzumab%22
Search /vufind/Search2/Results?lookfor=%22CK%22&type=Subject&filter%5B%5D=topic_facet%3A%22Trastuzumab%22
PubPharm (9.113)
1
Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer : recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines
enthalten in:
Breast cancer (Tokyo, Japan)
| 2024
von
Hattori, M.
|
Honma, N.
|
Nagai, S.
| +18
Wird geladen...
2
A Multifunctional Bimetallic Nanoplatform for Synergic Local Hyperthermia and Chemotherapy Targeting HER2-Positive Breast Cancer
enthalten in:
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
| 2024
von
Zhao, L.
|
Chang, F.
|
Tong, Y.
| +5
Wird geladen...
3
Establishment of a Novel Cancer-Specific Anti-HER2 Monoclonal Antibody H2Mab-250/H2CasMab-2 for Breast Cancers
enthalten in:
Monoclonal antibodies in immunodiagnosis and immunotherapy
| 2024
von
Kaneko, M.
|
Suzuki, H.
|
Kato, Y.
ErratumIn: Monoclon Antib Immunodiagn Immunother. 2024 Apr 16;:. - PMID 38625004
Wird geladen...
4
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain) : a randomised, open-label, phase 2 trial
enthalten in:
Lancet (London, England)
| 2024
von
Pérez-García, J.
|
Cortés, J.
|
Ruiz-Borrego, M.
| +27
Wird geladen...
5
Safe de-escalation of chemotherapy in HER2-positive early breast cancer
enthalten in:
Lancet (London, England)
| 2024
von
Earl, H.
Wird geladen...
6
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01) : primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
enthalten in:
The Lancet. Oncology
| 2024
von
Smit, E.
|
Felip, E.
|
Uprety, D.
| +17
Wird geladen...
7
Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine Diet
enthalten in:
Anticancer research
| 2024
von
Sato, M.
|
Han, Q.
|
Mori, R.
| +7
Wird geladen...
8
Fe3O4-Cy5.5-trastuzumab magnetic nanoparticles for magnetic resonance/near-infrared imaging targeting HER2 in breast cancer
enthalten in:
Biomedical materials (Bristol, England)
| 2024
von
Yin, Q.
|
Gao, X.
|
Zhang, H.
| +5
Wird geladen...
9
Chinese expert consensus on the management of clinical pathway and adverse events of trastuzumab deruxtecan (2024 edition)
enthalten in:
Zhonghua zhong liu za zhi [Chinese journal of oncology
| 2024
von
Trastuzumab Deruxtecan Clinical Management Pathway and Adverse Reaction Management Consensus Expert Group
Wird geladen...
10
Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer : A Multicenter, Single-Arm, Prospective Study
enthalten in:
Cancer research and treatment
| 2024
von
Jiang, K.
|
Hong, R.
|
Xia, W.
| +14
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[912]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Trastuzumab
Medienart
9.113
Aufsätze
7.250
E-Artikel
7.250
E-Ressourcen
1.863
Gedruckte Aufsätze
Zeitschriftentitel
335
Breast cancer research and treatment
306
Journal of clinical oncology : official journal...
225
Gan to kagaku ryoho. Cancer & chemotherapy
222
Clinical cancer research : an official journal ...
221
Annals of oncology : official journal of the Eu...
165
Clinical breast cancer
154
Breast (Edinburgh, Scotland)
136
The Lancet. Oncology
127
The oncologist
113
PloS one
112
British journal of cancer
111
BMC cancer
106
Cancer research
105
Anticancer research
97
European journal of cancer (Oxford, England : 1...
97
Scientific reports
92
Journal of the National Cancer Institute
83
Cancer chemotherapy and pharmacology
79
Oncotarget
78
Breast cancer research : BCR
Alle anzeigen ...
weniger ...
Thema
Trastuzumab
9.110
P188ANX8CK
8.295
Journal Article
5.877
EC 2.7.10.1
5.706
Receptor, ErbB-2
5.350
Antibodies, Monoclonal, Humanized
3.441
Antineoplastic Agents
3.301
Research Support, Non-U.S. Gov't
3.274
Antibodies, Monoclonal
2.691
ERBB2 protein, human
1.505
Review
780
Antineoplastic Agents, Immunological
723
Research Support, N.I.H., Extramural
702
Biomarkers, Tumor
677
Quinazolines
665
Lapatinib
653
Case Reports
652
0VUA21238F
646
Paclitaxel
645
Multicenter Study
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2.047
2020-
4.619
2010-2019
1.712
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
8.414
Englisch
295
Japanisch
127
Französisch
95
Chinesisch
61
Deutsch
21
Russisch
16
Italienisch
15
Spanisch
14
Ungarisch
9
Polnisch
7
Tschechisch
7
Niederländisch
7
Portugiesisch
5
Dänisch
5
Finnisch
4
Hebräisch
3
Norwegisch
3
Schwedisch
2
Slowakisch
1
Bulgarisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...